Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Dataset
|
Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implantsWu, Chunsheng ; Yi, Xiangting ; Xu, Renzhi ; Zhang, Maokuan ; Xu, Yan ; Ma, Yan ; Gao, Li ; Zha, ZhengbaoTaylor & Francis 2022Texto completo disponível |
|
2 |
Material Type: Dataset
|
DNA-PKcs RNASeq data: DNA-PKcs wilde-type or kinase-dead protein regulate basal and etoposide-induced gene expression changesAshley, AmandaDryad 2024Texto completo disponível |
|
3 |
Material Type: Dataset
|
RAD54L2 counters TOP2-DNA adducts to promote genome stability (Etoposide treated RPE1 CRISPR screens in TP53 and RAD53L2 knock outs)D'Alessandro, Giuseppina ; Morales-Juarez, David A. ; Richards, Sean ; Nitiss, Karin ; Serrano-Benitez, Almudena ; Wang, Juanjuan ; Thomas, John ; Gupta, Vipul ; Voigt, Andrea ; Belotserkovskaya, Rimma ; Goh, Chen Gang ; Bowden, Anne ; Galanty, Yaron ; Beli, Petra ; Nitiss, John ; Zagnoli-Vieira, Guido ; Jackson, StephenDryad 2023Texto completo disponível |
|
4 |
Material Type: Dataset
|
Supplementary Material for: Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin plus Etoposide TherapyM., Takahashi ; K., Takahashi ; H., Kaneda ; T., Kawaguchi ; T., Otori ; Y., NakamuraKarger Publishers 2023Texto completo disponível |
|
5 |
Material Type: Dataset
|
Supplementary Material for: Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin plus Etoposide TherapyM., Takahashi ; K., Takahashi ; H., Kaneda ; T., Kawaguchi ; T., Otori ; Y., NakamuraKarger Publishers 2023Texto completo disponível |
|
6 |
Material Type: Dataset
|
Supplementary Material for: Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin plus Etoposide TherapyM., Takahashi ; K., Takahashi ; H., Kaneda ; T., Kawaguchi ; T., Otori ; Y., NakamuraKarger Publishers 2023Texto completo disponível |
|
7 |
Material Type: Dataset
|
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosisVigneron, Clara ; Le Stang, Valentine ; Decroocq, Justine ; Péju, Edwige ; Burroni, Barbara ; Chapuis, Nicolas ; Charpentier, Julien ; Pène, FrédéricTaylor & Francis 2022Texto completo disponível |
|
8 |
Material Type: Dataset
|
Supplementary Material for: The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic LymphohistiocytosisNaymagon, L. ; Tremblay, D. ; Mascarenhas, J.Karger Publishers 2021Texto completo disponível |
|
9 |
Material Type: Dataset
|
Eco-friendly fluorimetric approaches for the simultaneous estimation of the co-administered ternary mixture: etoposide, moxifloxacin, and nalbuphineTolba, Manar ; Belal, Fathalla ; Salim, MohamedDryad 2021Texto completo disponível |
|
10 |
Material Type: Dataset
|
Supplemental Information: OLIE, ITCC-082: A phase 2 trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.docxGaspar, Nathalie ; Campbell-Hewson, Quentin ; Huang, Jie ; Okpara, Chinyere E. ; Bautista, FranciscoTaylor & Francis 2021Texto completo disponível |